Latest debt-to-equity ratio
Vistagen Therapeutics Debt-to-equity ratio
Direct answer
Vistagen Therapeutics's debt-to-equity ratio is 3.2%.
The verified market snapshot reports 3.2%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 3.2%
Explore related company data
View Vistagen Therapeutics's market capitalizationView Vistagen Therapeutics's price-to-book ratioView Vistagen Therapeutics's return on equityView Vistagen Therapeutics's dividend yieldView Vistagen Therapeutics's 52-week price rangeView Vistagen Therapeutics's revenue growthView Vistagen Therapeutics's profit marginView all Vistagen Therapeutics key metricsReturn to Vistagen Therapeutics profile